These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5792152)

  • 1. [Cost and prices of pharmaceutical products and their relation with the expenditures of the Sécurité Sociale].
    de Vernejoul R
    Therapeutique; 1969 Jan; 45(1):11-54. PubMed ID: 5792152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Attempt at reduction of expenditures of the Sécurité Sociale on pharmaceutical products].
    de Vernejoul R
    Therapeutique; 1969 Jan; 45(1):9-10. PubMed ID: 5792163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Supplement on standard prices of pharmaceutical products (4), (5) and a list of commercial names of standard drugs].
    Nihon Ishikai Zasshi; 1967 Aug; 58(3):267-333. PubMed ID: 5625979
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medicolegal expertise on lumbalgic casualties in industry within the context of the Sécurité Sociale].
    Nantermoz I; Faure J; Yacoub M; Gau G
    Med Leg Dommage Corpor; 1969; 2(1):79-81. PubMed ID: 4248668
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statistical study of 100 medicolegal expertise records of the Sécurité Sociale concerning lumbalgia].
    Dô JP; Arcadio F; Roche L
    Med Leg Dommage Corpor; 1969; 2(1):77-8. PubMed ID: 4248667
    [No Abstract]   [Full Text] [Related]  

  • 6. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical policy in Italy: towards a structural change?
    Ghislandi S; Krulichova I; Garattini L
    Health Policy; 2005 Apr; 72(1):53-63. PubMed ID: 15760698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implementing a regional health system: the viewpoint of the Sécurité Sociale].
    Léonard J
    Cah Sociol Demogr Med; 1973; 13(1):34-7. PubMed ID: 4718349
    [No Abstract]   [Full Text] [Related]  

  • 9. [The fee for drugs--a social political anachronism].
    Svenonius R
    Lakartidningen; 1969 Feb; 66(7):650-1. PubMed ID: 5768956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Work accidents in 1964. According to statistics of the Caisse nationale de Securité sociale].
    Veylon R
    Arch Mal Prof; 1966 Dec; 27(12):905-7. PubMed ID: 5995788
    [No Abstract]   [Full Text] [Related]  

  • 11. [Work accidents in 1962 and 1963 according to the statistics of the Caisse Nationale de Sécurité Sociale].
    Veylon R
    Arch Mal Prof; 1965; 26(10):609-11. PubMed ID: 5853840
    [No Abstract]   [Full Text] [Related]  

  • 12. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
    Pavenik N
    Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Work accidents in 1965 according to the statistics of the Caisse nationale de Sécurité sociale].
    Veylon R
    Arch Mal Prof; 1968 Mar; 29(3):161-3. PubMed ID: 5704322
    [No Abstract]   [Full Text] [Related]  

  • 14. [Total revisions of the drug price standard].
    Nihon Ishikai Zasshi; 1967 Oct; 58(7):649-795. PubMed ID: 5627835
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conversation with the Committee on the Basic Problems of Medical Care. 4].
    Takemi T
    Nihon Ishikai Zasshi; 1968 Oct; 60(7):663-7. PubMed ID: 5751702
    [No Abstract]   [Full Text] [Related]  

  • 16. [Records of Central Pharmaceutical Affairs Council for socialized medicine in Japan].
    Nihon Ishikai Zasshi; 1970 Aug; 64(3):447-85. PubMed ID: 5465788
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical reimbursement and drug cost control: the MAC experience in Maryland.
    Sawyer DO
    Inquiry; 1983; 20(1):76-87. PubMed ID: 6219949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalosporin prices rising in wake of Pryor bill.
    Barlow RD
    Hosp Mater Manage; 1991 Jul; 16(7):1, 12-3. PubMed ID: 10112311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statistical studies by the Sécurité Sociale (health insurance and thermalism)].
    Dany H; Foglierini J
    Presse Therm Clim; 1967; 104(2):73. PubMed ID: 5633161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.